TrialAdvances in therapy2022

Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study.

Junyu Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.